MedTrace Logo

Study Evaluating a Combined Administration of Lecozotan SR and Citalopram in Young Healthy Subjects

NCT00538889 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2007-12-11

No results posted yet for this study

Summary

To assess the safety and tolerability of lecozotan SR and citalopram when coadministred to healthy subjects.

Conditions

  • Healthy

Interventions

DRUG

Lecozotan SR

DRUG

Citalopram

Sponsors & Collaborators

  • Wyeth is now a wholly owned subsidiary of Pfizer

    lead INDUSTRY

Principal Investigators

  • Medical Monitor · Wyeth is now a wholly owned subsidiary of Pfizer

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Completion
2007-11-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00538889 on ClinicalTrials.gov